Pfizer (PFE), BioNTech (BNTX) rally amid COVID-19 vaccine hopes, stir other stocks

Pfizer and BioNTech have reported early yet promising results in developing a coronavirus vaccine.
Both NYSE:PFE and NASDAQ: BNTX are rallying in response.
The broader stock market also received a boost in response to the promising development.

Yohay Elam FXStreet

Pfizer Inc, NYSE: PFE, and BioNTech SE - ADR NASDAQ: BNTX are on the rise by tackling the most burning problem in the world – COVID-19. Scientific journal STAT reported that an initial trial held by both pharma companies was successful in creating antibodies among subjects.

The two companies tested four different vaccines among a large field of 30,000 healthy people in the US and Europe and will now continue with the next phases of trials, using the most successful solutions.

In a joint statement, Pfizer and BioNTech committed to producing a vaccine en masse – reaching over one billion in 2021.

S&P futures moved from being mixed to rising in response to the news that provides hope. It is essential to note that similar announcements by companies such as Moderna and Inovio have previously stirred markets.

Pfizer Stock Price

NYSE: PFE is trading around $34, kicking off trading on Wednesday to the upside. It previously topped $35 and remains well above Tuesday's closing price of $32.69.

The major pharmaceutical firm, based in New York, is famous for its erectile dysfunction drug but has a vast stock of medications. Gaining success – even if one shared with another firm – would solidify its position among its peers.

BioNTech comes to the COVID-19 front

BioNTech is a lesser-known company from Germany. The relatively young company was founded in 2008, at the height of the previous crisis, and trades under NASDAQ: BNTX.

Trading at BioNTech was halted after the announcement and for a good reason – BNTX shares leaped over 10% to kick off trading above the $76 price level before it eased back below $70. Nevertheless, the shares trade above the previous close levels.

Fighting coronavirus puts BioNTech in the spotlight and could allow it to grow. Other products may gain exposure.

Author

Yohay Elam

FXStreet

Yohay is in Forex since 2008 when he founded Forex Crunch, a blog crafted in his free time that turned into a fully-fledged currency website later sold to Finixio.

EUR/USD climbs to daily highs near 1.1820

EUR/USD now picks up pace and advances to the area of daily peaks north of the 1.1800 barrier at the end of the week. The pair’s decent move higher comes against the backdrop of a generalised lack of direction in the FX galaxy and the mild offered stance in the US Dollar.

GBP/USD trims losses, retests 1.3460

After briefly challenging its key 200-day SMA near 1.3440, GBP/USD now manages to regain some balance and revisit the 1.3460 zone on Friday. Cable’s pullback comes as the selling pressure on the Greenback gathers traction, reigniting some recovery in the risk-linked space.

Gold flirts with four-week highs past $5,200

Gold extends its rebound, climbing for a third consecutive session and pushing back above the $5,200 mark per troy ounce on Friday. The move higher continues to draw support from lingering geopolitical tensions and the ongoing uncertainty surrounding US trade policy, both of which are keeping safe-haven demand firmly in play.

Bitcoin, Ethereum and Ripple consolidate with short-term cautious bullish bias

Bitcoin, Ethereum and Ripple are consolidating near key technical areas on Friday, showing mild signs of stabilization after recent volatility. BTC holds above $67,000 despite mild losses so far this week, while ETH hovers around $2,000 after a rejection near its upper consolidation boundary.

Changing the game: International implications of recent tariff developments

The Supreme Court ruling on International Emergency Economic Powers Act (IEEPA) tariffs provides limited relief for the rest of the world, with weighted average tariff rates modestly lower.

Starknet unveils strkBTC, shielded Bitcoin transactions on Ethereum Layer 2

Starknet, the Ethereum Layer 2 network developed by StarkWare, today announced strkBTC, a wrapped Bitcoin asset that introduces optional shielding while preserving full DeFi composability.